'In this trial involving children 1 to 3 years of age with peanut allergy, epicutaneous immunotherapy for 12 months was superior to placebo in desensitizing children to peanuts and increasing the peanut dose that triggered allergic symptoms.'

https://www.nejm.org/doi/full/10.1056/NEJMoa2212895?query=featured_home